GENE logo

GENE Cash From Investing

Annual CFI

$75.30 K
+$285.20 K+135.87%

June 1, 2024

Summary

Performance

1-Year Change

+135.87%

3-Year Change

+113.47%

5-Year Change

+120.07%

15-Year Change

+169.66%

GENE Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

68.69%
GENE annual cash flow from investing activities is higher than 68.69% of companies in Healthcare sector

High & Low

All-time High

$4.88 M
GENE annual cash flow from investing activities is currently -98.46% below its historical high of $4.88 million

3-Year Low

-$2.51 M

Earnings dates

Last Annual Earnings Report Date

Jun 1, 2024
GENE previous annual earnings announcement was published on Jun 1, 2024

Next Annual Earnings Report Date

N/A
GENE next annual earnings announcement has not yet been scheduled

OtherGENEcash flowmetrics:

Annual CFF

$1.85 M
GENE annual cash flow from financing activities is $1.85 million

Annual CFO

-
GENE annual cash flow from operations value is unknown

Annual FCF

-
GENE annual free cash flow value is unknown

Annual CAPEX

$21.60 K
GENE annual capital expenditures is $21.60 thousand

Quarterly CFI

$16.80 K
-$55.50 K-76.76%

June 1, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+108.84%

3-Year Change

+108.84%

5-Year Change

+108.84%

GENE Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

69.26%
GENE quarterly cash flow from investing activities is higher than 69.26% of companies in Healthcare sector

High & Low

All-time High

$66.47 M
GENE quarterly cash flow from investing activities is currently -99.97% below its historical high of $66.47 million

3-Year Low

-$190.00 K

Earnings dates

Last Quarterly Earnings Report Date

Jun 1, 2024
GENE previous earnings announcement was published on Jun 1, 2024

Next Quarterly Earnings Report Date

N/A
GENE next earnings announcement has not yet been scheduled

OtherGENEcash flowmetrics:

Quarterly CFF

$1.57 M
GENE quarterly cash flow from financing activities is $1.57 million

Quarterly CFO

-
GENE quarterly cash flow from operations value is unknown

Quarterly FCF

-
GENE quarterly free cash flow value is unknown

Quarterly CAPEX

-
GENE quarterly capital expenditures value is unknown

TTM CFI

$89.10 K
+$206.80 K+175.70%

June 1, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+171.28%

3-Year Change

+171.28%

5-Year Change

+171.28%

GENE TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

69.17%
GENE TTM cash flow from investing activities is higher than 69.17% of companies in Healthcare sector

High & Low

All-time High

$66.47 M
GENE TTM cash flow from investing activities is currently -99.87% below its historical high of $66.47 million

3-Year Low

-$125.00 K

Earnings dates

Last Quarterly Earnings Report Date

Jun 1, 2024
GENE previous earnings announcement was published on Jun 1, 2024

Next Quarterly Earnings Report Date

N/A
GENE next earnings announcement has not yet been scheduled

OtherGENEcash flowmetrics:

TTM CFF

$1.46 M
GENE TTM cash flow from financing activities is $1.46 million

TTM CFO

-
GENE TTM cash flow from operations value is unknown

TTM FCF

-
GENE TTM free cash flow value is unknown

TTM CAPEX

-
GENE TTM capital expenditures value is unknown

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

GENE Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+135.9%+108.8%+171.3%
3 y3 years+113.5%+108.8%+171.3%
5 y5 years+120.1%+108.8%+171.3%

GENE Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+103.0%-76.8%+108.8%at high+171.3%
5 y5-yearat high+103.0%-76.8%+104.4%at high+118.2%
alltimeall time-98.5%+103.0%-100.0%+104.4%-99.9%+118.2%

Genetic Technologies Limited Cash From Investing History

DateAnnualQuarterlyTTM
Jun 2024
$75.30 K(-135.9%)
$16.80 K(-76.8%)
$89.10 K(-175.7%)
Dec 2023
-
$72.30 K(-138.1%)
-$117.70 K(-5.8%)
Jun 2023
-$209.90 K(-91.6%)
-$190.00 K(-392.3%)
-$125.00 K(-258.2%)
Dec 2022
-
$65.00 K(+364.3%)
$79.00 K(+34.8%)
Jun 2022
-$2.51 M(+349.0%)
$14.00 K(-68.6%)
$58.60 K(-190.2%)
Dec 2021
-
$44.60 K(-140.7%)
-$65.00 K(-86.7%)
Jun 2021
-$558.90 K(-1384.8%)
-$109.60 K(-71.2%)
-$489.60 K(+28.8%)
Dec 2020
-
-$380.00 K
-$380.00 K
Jun 2020
$43.50 K(-111.6%)
-
-
Jun 2019
-$375.10 K(-3888.9%)
-
-
Jun 2018
$9900.00(-109.2%)
-
-
Jun 2017
-$108.10 K(-49.9%)
-
-
Jun 2016
-$215.80 K(-113.1%)
-
-
Jun 2015
$1.65 M(+671.4%)
-
-
Jun 2014
$213.30 K(-216.2%)
-
-
DateAnnualQuarterlyTTM
Jun 2013
-$183.50 K(-136.1%)
-
-
Jun 2012
$507.70 K(>+9900.0%)
-
-
Jun 2011
$5000.00(-100.5%)
-
-
Jun 2010
-$916.80 K(+247.8%)
-
-
Jun 2009
-$263.60 K(+520.2%)
-
-
Jun 2008
-$42.50 K(-132.8%)
-
-
Jun 2007
$129.40 K(-210.8%)
-
-
Jun 2006
-$116.80 K(+514.7%)
-
-
Jun 2005
-$19.00 K(-97.1%)
-
-
Mar 2005
-
$66.47 M
$66.47 M
Jun 2004
-$654.00 K(+334.3%)
-
-
Jun 2003
-$150.60 K(-103.1%)
-
-
Jun 2002
$4.88 M(+473.8%)
-
-
Jun 2001
$851.00 K(+53.3%)
-
-
Jun 2000
$555.00 K
-
-

FAQ

  • What is Genetic Technologies Limited annual cash flow from investing activities?
  • What is the all time high annual CFI for Genetic Technologies Limited?
  • What is Genetic Technologies Limited annual CFI year-on-year change?
  • What is Genetic Technologies Limited quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Genetic Technologies Limited?
  • What is Genetic Technologies Limited quarterly CFI year-on-year change?
  • What is Genetic Technologies Limited TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Genetic Technologies Limited?
  • What is Genetic Technologies Limited TTM CFI year-on-year change?

What is Genetic Technologies Limited annual cash flow from investing activities?

The current annual CFI of GENE is $75.30 K

What is the all time high annual CFI for Genetic Technologies Limited?

Genetic Technologies Limited all-time high annual cash flow from investing activities is $4.88 M

What is Genetic Technologies Limited annual CFI year-on-year change?

Over the past year, GENE annual cash flow from investing activities has changed by +$285.20 K (+135.87%)

What is Genetic Technologies Limited quarterly cash flow from investing activities?

The current quarterly CFI of GENE is $16.80 K

What is the all time high quarterly CFI for Genetic Technologies Limited?

Genetic Technologies Limited all-time high quarterly cash flow from investing activities is $66.47 M

What is Genetic Technologies Limited quarterly CFI year-on-year change?

Over the past year, GENE quarterly cash flow from investing activities has changed by +$206.80 K (+108.84%)

What is Genetic Technologies Limited TTM cash flow from investing activities?

The current TTM CFI of GENE is $89.10 K

What is the all time high TTM CFI for Genetic Technologies Limited?

Genetic Technologies Limited all-time high TTM cash flow from investing activities is $66.47 M

What is Genetic Technologies Limited TTM CFI year-on-year change?

Over the past year, GENE TTM cash flow from investing activities has changed by +$214.10 K (+171.28%)